Compare, Analyse IPCA Labs with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs TEVA PHARMA (Israel) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   TEVA PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-19
TEVA PHARMA
Dec-13
IPCA LABS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0423,149-   
Low Rs5902,735-   
Sales per share (Unadj.) Rs298.61,807.2-  
Earnings per share (Unadj.) Rs35.0112.9-  
Cash flow per share (Unadj.) Rs49.4259.0-  
Dividends per share (Unadj.) Rs3.0098.83-  
Dividend yield (eoy) %0.43.4 10.9%  
Book value per share (Unadj.) Rs247.12,007.4-  
Shares outstanding (eoy) m126.35848.00-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.71.6 167.8%   
Avg P/E ratio x23.326.1 89.5%  
P/CF ratio (eoy) x16.511.4 145.3%  
Price / Book Value ratio x3.31.5 225.3%  
Dividend payout %8.687.5 9.8%   
Avg Mkt Cap Rs m103,1082,494,952 4.1%   
No. of employees `00013.444.9 29.9%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.034,097.0 8.2%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.02,130.0 15.4%   
INCOME DATA
Net Sales Rs m37,7321,532,488 2.5%  
Other income Rs m5770-   
Total revenues Rs m38,3091,532,488 2.5%   
Gross profit Rs m6,901419,673 1.6%  
Depreciation Rs m1,824123,872 1.5%   
Interest Rs m18930,101 0.6%   
Profit before tax Rs m5,465265,700 2.1%   
Minority Interest Rs m01,207 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-174,417 0.0%   
Tax Rs m1,042-3,244 -32.1%   
Profit after tax Rs m4,42295,733 4.6%  
Gross profit margin %18.327.4 66.8%  
Effective tax rate %19.1-1.2 -1,562.4%   
Net profit margin %11.76.2 187.6%  
BALANCE SHEET DATA
Current assets Rs m23,7781,035,037 2.3%   
Current liabilities Rs m10,975902,640 1.2%   
Net working cap to sales %33.98.6 392.7%  
Current ratio x2.21.1 188.9%  
Inventory Days Days10491 114.3%  
Debtors Days Days6696 68.7%  
Net fixed assets Rs m20,368500,544 4.1%   
Share capital Rs m2533,772 6.7%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,2241,702,304 1.8%   
Long term debt Rs m1,409783,595 0.2%   
Total assets Rs m45,5073,502,227 1.3%  
Interest coverage x30.09.8 304.9%   
Debt to equity ratio x00.5 9.8%  
Sales to assets ratio x0.80.4 189.5%   
Return on assets %10.13.6 282.0%  
Return on equity %14.25.6 251.8%  
Return on capital %17.34.9 351.3%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923244,199 2.0%  
From Investments Rs m-1,563-86,530 1.8%  
From Financial Activity Rs m-1,832-292,934 0.6%  
Net Cashflow Rs m1,528-135,264 -1.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.44 Rs / USD

Compare IPCA LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare IPCA LABS With: ORCHID PHARMA  J.B.CHEMICALS  DIVIS LABORATORIES  NEULAND LABS  STERLING BIOTECH  



Today's Market

Sensex Trades Marginally Lower, Dow Futures Up by 18 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 17 points, flat at 48,064 levels.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


Apr 23, 2021 01:23 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - ALKEM LABORATORIES COMPARISON

COMPARE IPCA LABS WITH

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS